Journal
VASCULAR AND ENDOVASCULAR SURGERY
Volume 44, Issue 6, Pages 421-433Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/1538574410363833
Keywords
statins; coronary artery disease; peripheral arterial disease; stroke; pleiotropic; hypercholesterolemia
Categories
Funding
- VA Merit Award
- VISN 2 Research Growth Fund
Ask authors/readers for more resources
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly known as statins, are the medical treatment of choice for hypercholesterolemia. In addition to achieving a therapeutic decrease in serum cholesterol levels, statin therapy appears to promote pleiotropic effects that are independent of changes in serum cholesterol. These cholesterol lowering and pleiotropic effects are beneficial not only for the coronary circulation, but for the myocardium and peripheral arterial system as well. Patients receiving statin therapy must be carefully monitored, however, as statins potentially have harmful side effects and drug interactions. This article is part II of a 2-part review, and it focuses on the clinical aspects of statin therapy in cardiovascular disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available